反応式
[CH2:1]([C:4]1[NH:8][C:7]2[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=2[N:5]=1)[CH2:2][CH3:3].Br[CH2:14][C:15]1[CH:35]=[CH:34][C:18]2/[C:19](=[C:30](/[CH3:33])\[C:31]#[N:32])/[C:20]3[CH:27]=[C:26]([F:28])[C:25]([F:29])=[CH:24][C:21]=3[O:22][CH2:23][C:17]=2[CH:16]=1>>[F:28][C:26]1[C:25]([F:29])=[CH:24][C:21]2[O:22][CH2:23][C:17]3[CH:16]=[C:15]([CH2:14][N:8]4[C:7]5[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=5[N:5]=[C:4]4[CH2:1][CH2:2][CH3:3])[CH:35]=[CH:34][C:18]=3/[C:19](=[C:30](/[CH3:33])\[C:31]#[N:32])/[C:20]=2[CH:27]=1参加物
3
実験手順
Using 2-propyl-1H-benzo[d]imidazole (Synthetic Communication, 2002, vol. 32, p 3703; 51 mg, 0.32 mmol) and (E)-2-[8-(bromomethyl)-2,3-difluorodibenzo[b,e]oxepin-11(6H)-ylidene]propanenitrile (120 mg, 0.32 mmol) obtained in Reference Example 3, and in the same manner as in Reference Example 1A, the title compound (132 mg, 91%) was obtained.
後処理
- customobtained in Reference Example 3
出典と根拠
- ORDレコード
- ord-485ff65f2e5541f9972806664e5b29fd
- 出典データセット
- uspto-grants-2015_03
- 特許番号
- US08969345B2
関連ノート
読み込み中…